Clinical trials

  • CEMDISIRAN for Paroxysmal nocturnal haemoglobinuria
  • MIDOSTAURIN for FLT3-mutated acute myeloid leukemia | Acute myeloid leukemia
  • UPADACITINIB for Crohn's disease
  • OXYGEN PH.EUR. for Prematurity | Very low birth weight
  • DOSTARLIMAB for Rectal adenocarcinoma | Locally advanced rectal cancer (dMMR/MSI-H)
  • CICLOSPORIN for Atopic dermatitis
  • LOXO-783 for Advanced breast cancer | Solid tumors
  • IRINOTECAN HYDROCHLORIDE TRIHYDRATE for Locally advanced rectal cancer
  • ZONGERTINIB for Metastatic gastric adenocarcinoma | Gastroesophageal junction adenocarcinoma | Esophageal adenocarcinoma | Metastatic breast cancer
  • Rituximab for Idiopathic steroid-sensitive nephrotic syndrome|Nephrotic syndrome
  • GUSELKUMAB for Juvenile psoriatic arthritis|Ulcerative colitis|Crohn's disease
  • Girentuximab labelled with astatine-211 ([211At]) for Non-muscle invasive bladder cancer (refractory)